Navigation Links
Study looks at new bladder cancer therapy for patients unresponsive to standard treatment
Date:2/26/2008

NEW YORK (Feb. 26, 2008) -- As many as half of patients with superficial bladder cancer do not respond to the standard first-line chemotherapy placed into the bladder, according to current multi-center outcomes data. When this happens, typically, their only option is surgical removal of the bladder. Now, researchers at the Herbert Irving Comprehensive Cancer Center of NewYork-Presbyterian Hospital and Columbia University Medical Center are investigating an FDA-approved metastatic breast-cancer drug called Abraxane that may prove a safe and effective alternative to surgery for these patients.

Bladder cancer is the fourth leading cause of cancer in men and the ninth leading cause of cancer in women in the United States. In a given year, more than 60,000 new cases are diagnosed, and 13,000 will die from the disease.

"When the standard treatment does not work, currently the only option is surgical removal of the bladder -- something that, for all patients, is unappealing, and for some sicker patients is not even possible. With this study, we hope to find an effective second line medical option for these patients," says Dr. James McKiernan, director of urologic oncology at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center, and vice chairman of the Department of Urology and assistant professor of urology at Columbia University College of Physicians and Surgeons.

The Phase I/II study will follow 18 patients for six weeks to assess dosage safety, followed by a second group of 19 patients who will be followed for six weeks to measure the effectiveness of the therapy.

The study is open to patients with recurrent bladder cancer that has not responded to standard therapy -- BCG (bacillus Calmette-Guerin) treatment.

In 2006, Dr. McKiernan, together with departmental chair Dr. Mitchell C Benson, led a phase I study of the drug Taxotere, also used to treat breast
'/>"/>

Contact: Jennifer Homa
jeh9057@nyp.org
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. LSU researchers study coastal community bounce back
2. Childrens Hospital 1 of 10 pediatric hospitals in US selected to study liver disease in kids
3. Yoga Journal Releases 2008 Yoga in America Market Study
4. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
5. Study finds recent trend of growing US disparities in health not inevitable
6. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
7. Faux Fido eases loneliness in nursing home residents as well as real dog, SLU study finds
8. Study details link between obesity, carbs and esophageal cancer
9. Interactive Patient Television Drives Patient Satisfaction, LodgeNet Healthcare Study Shows
10. Trial finds tenofovir gel safe for daily use and most women adhered to study regimens
11. Study finds spine surgery yields greater benefits over nonsurgical treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering the newly ... is a non-surgical method to dissolve fat cells and is the first of ... deposits under the chin, commonly known as a double chin. Dr. Green participated in ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The ... Hospital in Newport News, VA. The procedure was an L5-S1 posterior lumbar interbody ...
(Date:7/6/2015)... ... 06, 2015 , ... Thanks to donations and a generous grant from the ... Memory Certification for hospice patients and adult day center participants. , The Music & ... but also to their families and volunteers. Music & Memory is a non-profit organization ...
(Date:7/5/2015)... ... July 06, 2015 , ... Security ... excited to announce the next generation of PrimeStar Individual Dental Insurance. Beginning now, ... include two network options—Maximum Allowable Charge (MAC) and usual, customary and reasonable (UCR). ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in Wellness, powered by ... These classes are geared towards families that want their children to stay active as ... The fitness class will take place TUESDAYS at 4:30pm. Questions? Call 248-601-6683. Women’s ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... HealthDay Reporter , THURSDAY, April 7 (HealthDay News) -- ... struggle to maintain a healthy weight. "The first realization ... as after finishing the diet I put the weight I,d ... the Wurzburg region of Germany. "So, I researched surgical options ...
... held today will serve as the launch of a unique ... Agrupacin Mexicana para el Estudio de la Hematologa (AMEH), and ... goal: improving the care of patients with acute myeloid leukemia ... blood cancer characterized by rapid growth of abnormal white blood ...
... result in an increase in deaths due to alcohol? This was ... in Finland in 2004 (30% for spirits, 3% for wine).The abolition ... possible to import from other member countries and this led to ... paper is particularly interesting as it not only reports the effects ...
... 7, 2011) The American College of Gastroenterology published a ... Bowel Disease (IBD) as a supplement to The ... a special issue entirely dedicated to IBD. ... new graded recommendations on medical management of IBD, a ...
... 7, 2011A growing body of research suggests that caffeine ... and poor control of type 2 diabetes, a major ... issue of Journal of Caffeine Research : The ... journal from Mary Ann Liebert, Inc. publishers, examines the ...
... The American Society for Biochemistry and Molecular Biology ... L. Goldstein, pioneers in the study of cholesterol metabolism, ... Stadtman Distinguished Scientist Award. Brown and Goldstein will ... Applied to Cholesterol," at 2:40 p.m. April 11 at ...
Cached Medicine News:Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 2Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 3Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 4Health News:ASH partners with AMEH and National Cancer Institute to improve diagnosis of leukemia in Mexico 2Health News:Effects of a large reduction in alcohol prices on mortality in Finland 2Health News:Effects of a large reduction in alcohol prices on mortality in Finland 3Health News:Digestive experts grade treatment options for inflammatory bowel disease 2Health News:Digestive experts grade treatment options for inflammatory bowel disease 3Health News:Caffeine and diabetes -- helpful or harmful? 2Health News:Nobel laureates Brown, Goldstein to give inaugural Stadtman award lecture 2
(Date:7/3/2015)... A global continuing medical education provider is ... in Central and South-East Asia ... dedicated to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227090) ... Manage Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic ...
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the developer ... online service for the management of data on pharmaceutical ... that PharmaShine now includes the 2014 Open Payments General ... Services on June 30. The data disclosed on Open ... between industry and providers totaling $6.49 billion and is ...
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ... common shares have been approved for listing and trading on ... ESSA will begin trading on NASDAQ on July 9, ... Venture Exchange under the symbol "EPI". As a ... NASDAQ, each of the Company,s outstanding special warrants issued on ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4
... Nasdaq: WHRT ) - World Heart Corporation (WorldHeart) ... Bridge-to-Transplant (BTT) Study has been approved by the Institutional ... Oklahoma City. On-site clinical and technical training has ... for the Levacor Study. , Dr. Douglas Horstmanshof is ...
... MYL ) today announced that its subsidiary Mylan ... and Drug Administration (FDA) for its Abbreviated New Drug ... 25 mg. , Topiramate Capsules (Sprinkle) are the generic ... mg and 25 mg. For the 12 months ending ...
Cached Medicine Technology:WorldHeart Receives IRB Approval at First Center in the Levacor(TM) VAD BTT Clinical Trial 2
... Hemoccult SENSA fecal occult blood tests ... medical practice as a way to ... stool specimens, an early indication of ... that annual screening with Hemoccult will ...
... use of guaiac as a ... blood is based on the ... in guaiac to quinones, resulting ... blue color. If blood is ...
... is based on a natural human phenomenon ... woman's most fertile time, your body experiences ... released. At the same time, the elevated ... saliva. It is these salt crystals that ...
... occult blood test (FOBT) has been aiding physicians ... an early indication of colorectal cancer. More than ... which were conducted over long periods of time ... in leading medical journals around the world. As ...
Medicine Products: